GL1X · GenesisL1 explorer

MolNFT v1 · #117748 · protein

Rapid discovery of PYRIDO[3,4-D]PYRIMIDINE inhibitors of monopolar spindle kinase 1 (MPS1) using a structure-based hydridization approach

5EHL · Dual specificity protein kinase ttk: “Rapid discovery of PYRIDO[3,4-D]PYRIMIDINE inhibitors of monopolar spindle kinase 1 (MPS1) using a…”. X-ray diffraction, 1 ligand (0SQ), 1 pocket (best druggability 0.65). MolNFT v1 #117748 on…

PDB
5EHL
Type
protein
Length
258 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dual specificity protein kinase ttk
EC
2.7.12.1
UniProt
P33981
Ligands
0SQ
Pockets
1 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual specificity protein kinase ttk (EC 2.7.12.1)protein25838% helix, 21% strandP33981

Ligands and binding sites

  • 0SQ · 1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]urea · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13530.650.80320SQ

Compared structures

  • 5EHL · Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.